Marc Semigran's Net Worth
$1.97 Million
Who is Marc Semigran?
Marc Semigran has an estimated net worth of $1.97 Million. This is based on reported shares across multiple companies, which include Social Capital Suvretta Holdings Corp. III, MyoKardia Inc, Renovacor, Inc., and Edgewise Therapeutics, Inc..
SEC CIK
Marc Semigran's CIK is 0001691494
Past Insider Trading and Trends
2018 was Marc Semigran's most active year for acquiring shares with 6 total transactions. Marc Semigran's most active month to acquire stocks was the month of December. 2022 was Marc Semigran's most active year for disposing of shares, totalling 5 transactions. Marc Semigran's most active month to dispose stocks was the month of November. 2018 saw Marc Semigran paying a total of $730,482.32 for 88,652 shares, this is the most they've acquired in one year. In 2018 Marc Semigran cashed out on 90,000 shares for a total of $2,679,006.06, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Social Capital Suvretta Holdings Corp. III (PROK) Snapshot price: $2.41
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
MyoKardia Inc No price found
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 8
| |||
Form 4
| -31.78% | -517.00 |
$44.26 | -$22,879.94 | 1.11K |
Jan 7
| |||
Form 4
| +438.74% | 1.32K |
—
|
—
| 1.63K |
Jan 1
| |||
Form 4
|
∞
| 302 |
$42.16 | $12,732.32 | 302 |
Oct 31
| |||
Form 4
|
—
|
0
|
$37.74 | -$1,961,256.06 |
0
|
Scheduled
|
Sep 4 - Sep 5
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Renovacor, Inc. No price found
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -17.43K |
—
|
—
|
0
|
Dec 1
| |||
Form 4
| +49.47% | 17.43K |
—
|
—
| 52.65K |
Jan 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Edgewise Therapeutics, Inc. (EWTX) Snapshot price: $17.52
Chief Development Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||